Home / Consensus 2 / 2016 ESC-EAS Guidelines for the Management of Dyslipidaemias

2016 ESC-EAS Guidelines for the Management of Dyslipidaemias

2016 ESC-EAS Guidelines for the Management of Dyslipidaemias

The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR) Authors/Task Force Members:

Alberico L. Catapano* (Chairperson) (Italy), Ian Graham* (Chairperson) (Ireland), Guy De Backer (Belgium), OlovWiklund (Sweden), M. John Chapman (France), Heinz Drexel (Austria), ArnoW. Hoes
(The Netherlands), Catriona S. Jennings (UK), Ulf Landmesser (Germany), Terje R. Pedersen (Norway), Zeljko Reiner (Croatia), Gabriele Riccardi (Italy), Marja-Riita Taskinen (Finland), Lale Tokgozoglu (Turkey),W. M. Monique Verschuren (The Netherlands), Charalambos Vlachopoulos (Greece), David A.Wood (UK), Jose Luis Zamorano (Spain).

Additional Contributor: Marie-Therese Cooney (Ireland) Document Reviewers: Lina Badimon (CPG Review Coordinator) (Spain), Christian Funck-Brentano (CPG Review
Coordinator) (France), Stefan Agewall (Norway), Gonzalo Baro´ n-Esquivias (Spain), Jan Boren (Sweden), Eric Bruckert (France), Alberto Cordero (Spain), Alberto Corsini (Italy), Pantaleo Giannuzzi (Italy), Franc¸ois Gueyffier (France), Goran Krstacˇic´ (Croatia), Maddalena Lettino (Italy), Christos Lionis (Greece), Gregory Y. H. Lip (UK), Pedro Marques-Vidal (Switzerland), Davor Milicic (Croatia), Juan Pedro-Botet (Spain), Massimo F. Piepoli (Italy), Angelos G. Rigopoulos (Germany), Frank Ruschitzka (Switzerland), Jose Tunon (Spain), Arnold von Eckardstein (Switzerland), Michal Vrablik (Czech Republic), ThomasW.Weiss (Austria), BryanWilliams (UK), Stephan Windecker (Switzerland), and Reuven Zimlichman (Israel)

The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines.


• dyslipidaemias • cholesterol • triglycerides • low-density lipoproteins • high-density lipoproteins • apolipoprotein B • lipoprotein remnants • total cardiovascular risk • treatment, lifestyle • treatment, drugs • treatment, adherence

Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. A great number of guidelines have been issued in recent years by the European Society of Cardiology (ESC) and by the European Atherosclerosis Society (EAS), as well as by other societies and organisations.

Διαβάστε εδώ το πλήρες άθρο